Skip to content
Home/Companies/Biotech/Tridek-One
Tridek-One

Tridek-One

Biotech·France·Active·7yr hold
Entry
2019
Hold
7yr
Status
Active

Who owns Tridek-One?

Tridek-One is a French Biotech company, currently owned by AdBio Partners since 2019.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
AdBio Partners
Investor
AdBio Partners
AFB Seed-Fund · 2017 · VC

Key facts

HQFrance
SectorBiotech
Websitewww.tridekone.com

More from AFB Seed-Fund

Other portfolio companies in the same fund.

Alderaan Biotechnology
Active
BiotechFrance· 2020
ARTHEx Biotech
ARTHEx Biotech
Active
BiotechSpain· 2020
GAMUT Therapeutics
Exited 2021
BiotechFrance· 2020
to SparingVision
Kalsiom
Kalsiom
Active
BiotechFrance· 2020
Wellium
Active
HealthcareFrance· 2020
Agomab Therapeutics
Agomab Therapeutics
Exited 2026
BiotechBelgium· 2019
to Nasdaq (IPO)

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Tridek-One?

Tridek-One is currently owned by AdBio Partners, through AFB Seed-Fund, since 2019.

When did AdBio Partners acquire Tridek-One?

AdBio Partners acquired Tridek-One in 2019.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue